TR199902963T2 - Composition containing 5-$4-$2-(N-Methyl-N-2-Pyridyl)Amino)Ethoxy]Benzyl]Thiazolidine-2,4-Dion - Google Patents

Composition containing 5-$4-$2-(N-Methyl-N-2-Pyridyl)Amino)Ethoxy]Benzyl]Thiazolidine-2,4-Dion

Info

Publication number
TR199902963T2
TR199902963T2 TR1999/02963T TR9902963T TR199902963T2 TR 199902963 T2 TR199902963 T2 TR 199902963T2 TR 1999/02963 T TR1999/02963 T TR 1999/02963T TR 9902963 T TR9902963 T TR 9902963T TR 199902963 T2 TR199902963 T2 TR 199902963T2
Authority
TR
Turkey
Prior art keywords
dion
thiazolidine
pyridyl
ethoxy
benzyl
Prior art date
Application number
TR1999/02963T
Other languages
Turkish (tr)
Inventor
Patel Jai
Ross Hamish
Price Robin
Roger Granett Jeffrey
Nigel Wray Paul
Original Assignee
Smithkline Beecham P.L.C.
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en
Application filed by Smithkline Beecham P.L.C., Smithkline Beecham Corporation filed Critical Smithkline Beecham P.L.C.
Publication of TR199902963T2 publication Critical patent/TR199902963T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Terkibin farmasötik olarak kabul edilebilir formda ve farmasötik olarak kabul edilebilir bir tasiyici içinde 2 ila 12 mg Bilesik (I) içermesi ile karakterize edilen bir terkip; böyle bir terkibin ilaç yapiminda kullanilmasi; böyle bir terkibin ve böyle bir proseste faydali bir ara terkibin hazirlanmasi için prosesler.A composition characterized in that the composition contains 2 to 12 mg of Compound (I) in a pharmaceutically acceptable form and in a pharmaceutically acceptable carrier; use of such a composition in medicine; processes for the preparation of such a composition and an intermediate composition useful in such a process.

TR1999/02963T 1997-06-05 1998-06-02 Composition containing 5-$4-$2-(N-Methyl-N-2-Pyridyl)Amino)Ethoxy]Benzyl]Thiazolidine-2,4-Dion TR199902963T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9711683.4A GB9711683D0 (en) 1997-06-05 1997-06-05 Composition
GBGB9712851.6A GB9712851D0 (en) 1997-06-18 1997-06-18 Composition

Publications (1)

Publication Number Publication Date
TR199902963T2 true TR199902963T2 (en) 2000-02-21

Family

ID=26311662

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2000/02790T TR200002790T2 (en) 1997-06-05 1998-06-02 Composition containing 5- (4- (2- (N-methyl-N-2-pyridyl) amino) ethoxy) benzyl) thiazolidin-2,4-dione
TR1999/02963T TR199902963T2 (en) 1997-06-05 1998-06-02 Composition containing 5-$4-$2-(N-Methyl-N-2-Pyridyl)Amino)Ethoxy]Benzyl]Thiazolidine-2,4-Dion

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2000/02790T TR200002790T2 (en) 1997-06-05 1998-06-02 Composition containing 5- (4- (2- (N-methyl-N-2-pyridyl) amino) ethoxy) benzyl) thiazolidin-2,4-dione

Country Status (29)

Country Link
EP (1) EP0998284A1 (en)
JP (1) JP2001521553A (en)
KR (1) KR20010013410A (en)
CN (3) CN1112926C (en)
AP (1) AP1214A (en)
AR (2) AR008198A1 (en)
AU (1) AU8215098A (en)
BG (1) BG104048A (en)
BR (1) BR9810405A (en)
CA (2) CA2333352A1 (en)
CO (1) CO4940400A1 (en)
DZ (1) DZ2510A1 (en)
EA (1) EA002384B1 (en)
GB (1) GB9711683D0 (en)
HU (1) HUP0004070A3 (en)
ID (1) ID24264A (en)
IL (1) IL133074A0 (en)
MX (1) MXPA99011322A (en)
NO (2) NO995938L (en)
NZ (2) NZ523725A (en)
OA (1) OA11306A (en)
PE (1) PE78899A1 (en)
PL (1) PL337201A1 (en)
SK (1) SK164899A3 (en)
TR (2) TR200002790T2 (en)
TW (1) TW570797B (en)
UY (1) UY25032A1 (en)
WO (1) WO1998055122A1 (en)
ZA (2) ZA984826B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
CO5170421A1 (en) 1999-04-23 2002-06-27 Smithkline Beecham Plc NEW MALEICO PHARMACEUTICAL COMPOUND
DZ3155A1 (en) 1999-04-23 2000-11-02 Smithkline Beecham Plc New pharmaceutical composition.
GB0021978D0 (en) 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
GB0127805D0 (en) * 2001-11-20 2002-01-09 Smithkline Beecham Plc Pharmaceutical composition
GB0129871D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
AU2002350965A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0130509D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
DE06252444T8 (en) * 2006-05-09 2009-03-19 Teva Pharmaceutical Industries Ltd. 2-N- {5 - [[4- [2- (Methyl-2-pyridinylamino) -ethoxy] -phenyl] -methyl] -2,4-thiazolidinedione-succinic acid, method of preparation and compositions with rosiglitazone maleate
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2015008234A1 (en) * 2013-07-17 2015-01-22 Glenmark Pharmaceuticals S.A. Bicyclic heterocyclic compounds as ror gamma modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (en) * 1987-09-04 2000-05-11 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
EP0777469A1 (en) * 1994-02-10 1997-06-11 Smithkline Beecham Plc Use of insulin sensitisers for treating renal diseases
CN1192683A (en) * 1995-08-10 1998-09-09 沃尼尔·朗伯公司 Method for reducing amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus
AU7604596A (en) * 1995-11-17 1997-06-11 Warner-Lambert Company A method of treating myotonic dystrophy
NZ314406A (en) * 1996-03-18 2000-12-22 Sankyo Co Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
CN1230114A (en) * 1996-07-12 1999-09-29 史密丝克莱恩比彻姆有限公司 Novel treatment of leptine resistance

Also Published As

Publication number Publication date
OA11306A (en) 2003-10-22
IL133074A0 (en) 2001-03-19
BG104048A (en) 2000-07-31
GB9711683D0 (en) 1997-08-06
NZ513922A (en) 2001-09-28
CN1430959A (en) 2003-07-23
TW570797B (en) 2004-01-11
CN1112926C (en) 2003-07-02
BR9810405A (en) 2000-08-29
TR200002790T2 (en) 2001-11-21
KR20010013410A (en) 2001-02-26
NO995938L (en) 2000-02-02
CA2292629C (en) 2004-01-06
HUP0004070A2 (en) 2002-02-28
ZA9811572B (en) 1999-07-22
AP1214A (en) 2003-10-08
DZ2510A1 (en) 2003-01-25
NO995938D0 (en) 1999-12-03
AR008198A1 (en) 1999-12-29
JP2001521553A (en) 2001-11-06
HUP0004070A3 (en) 2002-03-28
CN1259050A (en) 2000-07-05
NO20040738L (en) 2000-02-02
UY25032A1 (en) 1998-11-26
CO4940400A1 (en) 2000-07-24
AP9901696A0 (en) 1999-12-31
AU8215098A (en) 1998-12-21
CA2292629A1 (en) 1998-12-10
NZ523725A (en) 2004-09-24
AR015120A1 (en) 2001-04-18
ZA984826B (en) 1999-08-03
EA199901116A1 (en) 2000-06-26
CN1526391A (en) 2004-09-08
PL337201A1 (en) 2000-08-14
CA2333352A1 (en) 1998-12-10
MXPA99011322A (en) 2004-12-02
ID24264A (en) 2000-07-13
EP0998284A1 (en) 2000-05-10
PE78899A1 (en) 1999-10-22
WO1998055122A1 (en) 1998-12-10
EA002384B1 (en) 2002-04-25
SK164899A3 (en) 2000-11-07

Similar Documents

Publication Publication Date Title
PL319833A1 (en) Compounds and composition for carrying active media
TR199902963T2 (en) Composition containing 5-$4-$2-(N-Methyl-N-2-Pyridyl)Amino)Ethoxy]Benzyl]Thiazolidine-2,4-Dion
GEP20012388B (en) Metalloproteinase Inhibitors, Pharmaceutical Compositions on Their Base, Use and Methods for Obtaining and Intermediates
EP1093819A3 (en) Compounds and compositions for delivering active agents
TW349946B (en) Novel naphthyl compounds and their process for preparation and pharmaceutical compositions containing same
PL341054A1 (en) Novel suppositiories containing an active compound being unstable in acid environments
GEP20043163B (en) Inhibitors of Caspases, Pharmaceutical Composition on its Base and Method for its Production
YU37301A (en) Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
GB2277872B (en) Pharmaceutical compositions containing nifedipine and process for the preparation thereof
GEP20032943B (en) Oral Composition of Levosimendan
FR2735369B1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON SODIUM SALT OF DICLOFENAC AND THIOCOLCHICOSIDE
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
GEP20043298B (en) Branched Chain Amino Acid-Dependent Aminotransferase Inhibitors and Their Use in Treatment of Diabetic Retinopathy
HUP0104206A2 (en) High purity composition comprising (7alpha,17alpha)- 17-hydroxy- 7-methyl- 19nor-17-pregn-5(10)-en-20-yn-3-one and process for its preparation
IL124296A0 (en) Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase
AR019331A2 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN INSULIN SENSITIZER AND AN INSULIN SECRETAGOG.
MX9709453A (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form.
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
HK1001822A1 (en) Medicinal form for oral application for the once-a-day treatment of hypertension by diltiazem hydrochloride
GB1535778A (en) Compounds useful in treatment of unipolar depression
TR199900141T2 (en) Formulation for the treatment and/or prophylaxis of dementia.
ZA901945B (en) Therapeutic agents
NZ510672A (en) Composition comprising 5-[4-[2-(N-Methyl-N-2-Pyridyl)Amino)-Ethoxy]Benzyl]Thiazolidine-2,4-Dione
MX9100974A (en) HYBRID FIBRINOLYTIC ENZYME AND PROCEDURE FOR ITS PREPARATION.